Social Capital Hedosophia III (IPOC) Shareholders Approve Clover Health Deal
by Nicholas Alan Clayton on 2021-01-06 at 1:37pm

Social Capital Hedosophia Holdings Corporation III (NYSE:IPOC) shareholders approved its business combination with Medicaid insurer Clover Health at a special meeting earlier today.

The company said in a press release that 65% of shares participated in the vote and about 99.5% voted in favor of the deal. Social Capital III initially announced its $3.7 billion deal with Clover Health on October 6. Clover is the fastest-growing private insurer covering members through the Medicaid Advantage program.

The parties aim to close the transaction tomorrow, January 7, which will be the last day Social Capital III will trade on the NYSE. The combined entity’s shares and warrants are then to transfer to the Nasdaq and trade under the ticker symbols “CLOV” and “CLOVW,” respectively beginning January 8.

Clover CEO Vivek Garipalli told CNBC at the time of the deal announcement that the company was initially set on an IPO track in early 2020. But, uncertainty about potential healthcare policy changes under a new administration made a SPAC-listing an easier path. That political change is now a reality, but has not dampened market enthusiasm for Clover as it opened at $15.39 ahead of the vote.

This was a significantly more confident trading value that Social Capital I (NYSE:SPCE) had going into the morning of its approval vote for Virgin Galactic in 2019, which opened at $10.62 at the time. But, the Clover transaction for now remains the market’s second favorite Chamath Palihapitiya SPAC production, with Social Capital II’s (NYSE:OPEN) deal with OpenDoor opening at $26.69 ahead of its December 17 approval vote and now trades above $27.

Social Capital Hedosophia III (IPOC) Shareholders Approve Clover Health Deal
Recent Posts
by Nicholas Alan Clayton on 2025-07-14 at 12:51pm

Cayson Acquisition Corp. (NASDAQ:CAPN) has entered into a definitive agreement to combine with boutique investment firm Mango Financial for $300 million in equity consideration. Hong Kong-based Mango provides a range of M&A and equity capital markets advisory services to clients considering listings in China and the US. The combined company is expected to trade on...

by Nicholas Alan Clayton on 2025-07-14 at 11:13am

Trailblazer (NASDAQ:BLZRU) has filed for a $200 million SPAC to bring a first-time team to market with serial sponsor terms. The new SPAC is offering investors a 1/3 warrant in each unit and it is the first SPAC filed so far this month with 24 months on its initial transaction clock. All other July SPACs...

by Kristi Marvin on 2025-07-14 at 9:19am

This week, we speak with Kyivstar CEO Oleksandr Komarov about the company’s $2.2 billion dollar combination with Cohen Circle Acquisition Corp. I (NASDAQ:CCIR). Few companies have been had to forge themselves in the flames recently quite like Ukraine’s leading telecom and digital services provider Kyivstar. Now, Kyivstar is not only telling that story but pitching it to...

by Nicholas Alan Clayton on 2025-07-14 at 8:30am

At the SPAC of Dawn The market still has one full trading session before it adds Tuesday’s Core CPI reading and a variety of Fed comments to messaging it is already ingesting on US President Donald Trump’s ever-shifting tariff policy. SPACs are meanwhile continuing on with business as usual, with Cayson (NASDAQ:CAPN) announcing the third...

by Kristi Marvin on 2025-07-12 at 10:02am

Terms Tracker for the Week Ending July 11, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. One more IPO priced this week bringing July’s total to 8. However, there are still three more weeks left in the month so that number...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved